Brief: Arovella Therapeutics Says Termination Of Licence And Supply Agreement With Teva Pharmaceuticals
13/06/2024 02:22
June 13 (Reuters) - Arovella Therapeutics ALA.AX :
* TERMINATION OF LICENCE AND SUPPLY AGREEMENT WITH TEVA
PHARMACEUTICALS
Further company coverage: ALA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO